Immunohistochemical expression of intermediate filaments in diagnostics of diffuse gliomas.
DOI:
https://doi.org/10.26641/2307-0404.2017.3.111932Ключові слова:
brain tumor, immunohistochemistry, diagnostics, vimentin, GFAPАнотація
Intermediate filament proteins play an important role in maintaining a stable shape, as well as the possible movement of cells, including neoplastic cells. However there, are few works dedicated to the investigation of these proteins expression in diffuse gliomas and they are quite contradictory. The authors studied the expression of intermediate filaments (glial fibrillar acid protein GFAP, vimentin) in diffuse gliomas of the brain. 52 postoperative samples with the diagnosis of astrocytic and oligodendroglial brain tumors were examined. Primary antibodies against GFAP, vimentin, Ki-67 were used. The proliferative index and the expression area were calculated using the tools ImageJ 1.47v. The statistical Fisher test was included. Most samples with moderate expression of GFAP (62.5%) are rated to oligodendroglial tumors. Partof oligodendroglial tumors (58.3%) showed no expression of vimentin by tumor cells,this was not observed in astrocytomas. Meanwhile, a high level of expression of intermediate filament proteins - GFAP (100%) and vimentin (87%) is characteristic for diffuse gliomas. The expression level of GFAP and vimentin is higher in astrocytic tumors than in oligodendroglial (p<0.05). Levels of GFAP and vimentin expression are differential feature of astrocytic and oligodendroglial tumors.
Посилання
1. Antomonov M. [Mathematical processing and analysis of medical and biological data.] Kyiv, FMD. 2006;558. Russian.
2. Poslavska OV. [Methodology for the use of software for the analysis of digital micrographs on the base of pathomorphology course in order to increase the professional level of students and scientists]. Morphologia. 2015;9(3):122-6. Ukrainian.
3. Shpon‘ka IS, Shynkarenko TV, Poslavska OV. [Characteristics and analysis of Ki-67-immunoreactivity in brain astrocytoma]. Morphologia. 2016;10(1):96-101. Ukrainian.
4. Dabbs DJ. Diagnostic immunohistochemistry. Elsevier Health Sciences; 2013.
5. Bai HX, Zou Y, Lee AM, Tang X, Zhang P, Yang L. Does morphological assessment have a role in classifying oligoastrocytoma as' oligodendroglial'versus' astrocytic'?. Histopathology. 2016;68(7):1114-5. doi: 10.1111/his.12891.
6. Lepekhin EA, Eliasson C, Berthold CH, Berezin V, Bock E, Pekny M. Intermediate filaments regulate astrocyte motility. Journal of neurochemistry. 2001;79(3):617-25. doi: 10.1046/j.1471-4159.2001.00595.x.
7. Kidd ME, Shumaker DK, Ridge KM. The role of vimentin intermediate filaments in the progression of lung cancer. American journal of respiratory cell and molecular biology. 2014;50(1):1-6. doi: 10.1165/rcmb.2013-0314TR.
8. Lépinoux-Chambaud C, Eyer J. Review on intermediate filaments of the nervous system and their pathological alterations. Histochemistry and cell biology. 2013;140(1):13-22. doi:10.1007/s00418-013-1101-1.
9. Li L, Lundkvist A, Andersson D, Wilhelmsson U, Nagai N, Pardo AC, Nodin C, Ståhlberg A, Aprico K, Larsson K, Yabe T. Protective role of reactive astrocytes in brain ischemia. Journal of Cerebral Blood Flow & Metabolism. 2008;28(3):468-81. doi: 10.1038/sj.jcbfm.9600546.
10. Ikota H, Kinjo S, Yokoo H, Nakazato Y. Systematic immunohistochemical profiling of 378 brain tumors with 37 antibodies using tissue microarray technology. Acta neuropathologica. 2006;111(5):475-482. doi: 10.1007/s00401-006-0060-1.
11. Yachnis AT, Rivera-Zengotita ML. Neuropathology, A Volume in the High Yield Pathology Series (Expert Consult-Online and Print), 1: Neuropathology. Elsevier Health Sciences; 2013.
12. Cavenee WK, Leung SY, Hawkins C, Van Meir EG, Burger PC, & Tabori U WHO Classification of Tumours of the Central Nervous System, Revised. ISBN 978-92-832-4492-9.
##submission.downloads##
Як цитувати
Номер
Розділ
Ліцензія
Авторське право (c) 2017 Медичні перспективи
Ця робота ліцензується відповідно до Creative Commons Attribution 4.0 International License.
Submitting manuscript to the journal "Medicni perspektivi" the author(s) agree with transferring copyright from the author(s) to publisher (including photos, figures, tables, etc.) editor, reproducing materials of the manuscript in the journal, Internet, translation into other languages, export and import of the issue with the author’s article, spreading without limitation of their period of validity both on the territory of Ukraine and other countries. This and other mutual duties of the author and all co-authors separately and editorial board are secured by written agreement by special form to use the article, the sample of which is presented on the site.
Author signs a written agreement and sends it to Editorial Board simultaneously with submission of the manuscript.
